CLUSTER filed Sep 9, 2026 at 16:02 ET
A cluster of insider selling at Artiva Biotherapeutics, totaling $477K in open-market sales by the CEO, COO/CLO, CTO, and CMO over a 5-day window. The CEO's $256K sale on Sept 8 is the largest, and the selling is concentrated among top C-suite executives. While the dollar amount is modest relative to the $532M market cap (~0.09%), the breadth of C-suite participation is notable. The cross-filing context shows the CEO also sold $256K in a separate transaction on the same day, reinforcing the pattern. The stock trades near $11, with 92% analyst bullishness, creating a tension between insider behavior and street sentiment.